Chris Henstridge, PhD - Publications

University of Edinburgh, Edinburgh, Scotland, United Kingdom 

25/33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Jackson RJ, Rose J, Tulloch J, Henstridge C, Smith C, Spires-Jones TL. Clusterin accumulates in synapses in Alzheimer's disease and is increased in apolipoprotein E4 carriers. Brain Communications. 1: fcz003. PMID 31853523 DOI: 10.1093/braincomms/fcz003  0.88
2019 Pickett EK, Herrmann AG, McQueen J, Abt K, Dando O, Tulloch J, Jain P, Dunnett S, Sohrabi S, Fjeldstad MP, Calkin W, Murison L, Jackson RJ, Tzioras M, Stevenson A, ... ... Henstridge CM, et al. Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease. Cell Reports. 29: 3592-3604.e5. PMID 31825838 DOI: 10.1016/J.Celrep.2019.11.044  0.88
2019 Henstridge CM, Hyman BT, Spires-Jones TL. Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis. Nature Reviews. Neuroscience. 20: 94-108. PMID 30643230 DOI: 10.1038/S41583-018-0113-1  0.88
2018 Pickett EK, Rose J, McCrory C, McKenzie CA, King D, Smith C, Gillingwater TH, Henstridge CM, Spires-Jones TL. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease. Acta Neuropathologica. PMID 30191401 DOI: 10.1007/S00401-018-1903-2  0.88
2018 Henstridge CM, Spires-Jones TL. Modeling Alzheimer's disease brains in vitro. Nature Neuroscience. PMID 29950667 DOI: 10.1038/S41593-018-0177-2  0.88
2017 Henstridge CM, Sideris DI, Carroll E, Rotariu S, Salomonsson S, Tzioras M, McKenzie CA, Smith C, von Arnim CAF, Ludolph AC, Lulé D, Leighton D, Warner J, Cleary E, Newton J, et al. Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathologica. PMID 29273900 DOI: 10.1007/S00401-017-1797-4  0.88
2017 Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Muñoz L, Querol-Vilaseca M, Martín-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O, Núñez-Llaves R, Blesa R, Smith C, McKenzie CA, Frosch MP, et al. Synaptic phosphorylated α-synuclein in dementia with Lewy bodies. Brain : a Journal of Neurology. 140: 3204-3214. PMID 29177427 DOI: 10.1093/Brain/Awx275  0.88
2017 Pickett EK, Henstridge CM, Allison E, Pitstick R, Pooler A, Wegmann S, Carlson G, Hyman BT, Spires-Jones TL. Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease. Synapse (New York, N.Y.). PMID 28196395 DOI: 10.1002/Syn.21965  0.88
2016 Pickett EK, Koffie RM, Wegmann S, Henstridge CM, Herrmann AG, Colom-Cadena M, Lleo A, Kay KR, Vaught M, Soberman R, Walsh DM, Hyman BT, Spires-Jones TL. Non-Fibrillar Oligomeric Amyloid-β within Synapses. Journal of Alzheimer's Disease : Jad. PMID 27258414 DOI: 10.3233/Jad-160007  0.44
2016 Henstridge CM, Pickett E, Spires-Jones TL. Synaptic pathology: a shared mechanism in neurological disease. Ageing Research Reviews. PMID 27108053 DOI: 10.1016/J.Arr.2016.04.005  0.88
2015 Henstridge CM, Jackson RJ, Kim JM, Herrmann AG, Wright AK, Harris SE, Bastin ME, Starr JM, Wardlaw J, Gillingwater TH, Smith C, McKenzie CA, Cox SR, Deary IJ, Spires-Jones TL. Erratum to: Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse. Acta Neuropathologica Communications. 3: 83. PMID 26651483 DOI: 10.1186/s40478-015-0244-9  0.88
2015 Henstridge CM, Jackson RJ, Kim JM, Herrmann AG, Wright AK, Harris SE, Bastin ME, Starr JM, Wardlaw J, Gillingwater TH, Smith C, McKenzie CA, Cox SR, Deary IJ, Spires-Jones TL. Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse. Acta Neuropathologica Communications. 3: 53. PMID 26335101 DOI: 10.1186/S40478-015-0232-0  0.88
2015 Lee SH, Ledri M, Tóth B, Marchionni I, Henstridge CM, Dudok B, Kenesei K, Barna L, Szabó SI, Renkecz T, Oberoi M, Watanabe M, Limoli CL, Horvai G, Soltesz I, et al. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 10039-57. PMID 26157003 DOI: 10.1523/Jneurosci.4112-14.2015  0.44
2015 Neuhofer D, Henstridge CM, Dudok B, Sepers M, Lassalle O, Katona I, Manzoni OJ. Functional and structural deficits at accumbens synapses in a mouse model of Fragile X. Frontiers in Cellular Neuroscience. 9: 100. PMID 25859182 DOI: 10.3389/Fncel.2015.00100  0.44
2015 Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature Neuroscience. 18: 75-86. PMID 25485758 DOI: 10.1038/Nn.3892  0.44
2014 Horváth E, Woodhams SG, Nyilas R, Henstridge CM, Kano M, Sakimura K, Watanabe M, Katona I. Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. The European Journal of Neuroscience. 39: 419-34. PMID 24494682 DOI: 10.1111/Ejn.12470  0.44
2012 Jung KM, Sepers M, Henstridge CM, Lassalle O, Neuhofer D, Martin H, Ginger M, Frick A, DiPatrizio NV, Mackie K, Katona I, Piomelli D, Manzoni OJ. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nature Communications. 3: 1080. PMID 23011134 DOI: 10.1038/Ncomms2045  0.44
2012 Henstridge CM. Off-target cannabinoid effects mediated by GPR55. Pharmacology. 89: 179-87. PMID 22433274 DOI: 10.1159/000336872  0.44
2011 Henstridge CM, Balenga NA, Kargl J, Andradas C, Brown AJ, Irving A, Sanchez C, Waldhoer M. Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55. Molecular Endocrinology (Baltimore, Md.). 25: 1835-48. PMID 21964594 DOI: 10.1210/me.2011-1197  0.44
2011 Balenga NA, Henstridge CM, Kargl J, Waldhoer M. Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55. Advances in Pharmacology (San Diego, Calif.). 62: 251-77. PMID 21907912 DOI: 10.1016/B978-0-12-385952-5.00004-X  0.44
2010 Henstridge CM, Balenga NA, Schröder R, Kargl JK, Platzer W, Martini L, Arthur S, Penman J, Whistler JL, Kostenis E, Waldhoer M, Irving AJ. GPR55 ligands promote receptor coupling to multiple signalling pathways. British Journal of Pharmacology. 160: 604-14. PMID 20136841 DOI: 10.1111/J.1476-5381.2009.00625.X  0.44
2010 Daly CJ, Ross RA, Whyte J, Henstridge CM, Irving AJ, McGrath JC. Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries. British Journal of Pharmacology. 159: 787-96. PMID 20136833 DOI: 10.1111/J.1476-5381.2009.00608.X  0.44
2009 Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 183-93. PMID 18757503 DOI: 10.1096/Fj.08-108670  0.44
2007 McDonald NA, Henstridge CM, Connolly CN, Irving AJ. Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging. Molecular and Cellular Neurosciences. 35: 237-48. PMID 17467290 DOI: 10.1016/j.mcn.2007.02.016  0.44
2007 McDonald NA, Henstridge CM, Connolly CN, Irving AJ. An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor. Molecular Pharmacology. 71: 976-84. PMID 17182888 DOI: 10.1124/mol.106.029348  0.44
Low-probability matches
2017 Paolicelli RC, Jawaid A, Henstridge CM, Valeri A, Merlini M, Robinson JL, Lee EB, Rose J, Appel S, Lee VM, Trojanowski JQ, Spires-Jones T, Schulz PE, Rajendran L. TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss. Neuron. PMID 28669544 DOI: 10.1016/J.Neuron.2017.05.037  0.08
2019 Kennedy L, Wilkinson H, Henstridge C. 'Buddy Pairs': A novel pilot scheme crafting knowledge exchange between biomedical dementia researchers and people affected by dementia - Innovative practice. Dementia (London, England). 1471301219885543. PMID 31718269 DOI: 10.1177/1471301219885543  0.01
2019 Henstridge CM, Tzioras M, Paolicelli RC. Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration. Frontiers in Cellular Neuroscience. 13: 63. PMID 30863284 DOI: 10.3389/fncel.2019.00063  0.01
2018 Hesse R, Henstridge CM. FENS-Kavli winter symposium: addressing the cellular phase of dementia - visions of the UK Dementia Research Institute. The European Journal of Neuroscience. PMID 29949652 DOI: 10.1111/ejn.14059  0.01
2016 Henstridge CM, Brown AJ, Waldhoer M. GPR55: Metabolic Help or Hindrance? Trends in Endocrinology and Metabolism: Tem. PMID 27215467 DOI: 10.1016/J.Tem.2016.04.012  0.01
2016 Pickett E, Henstridge C, Jackson RJ, Herrmann AG, Wegmann S, Hyman BT, Carlson GA, Spires-Jones TL. EC-03-03: Tau Spreading and Toxicity Alzheimer's & Dementia. 12: P269-P269. DOI: 10.1016/J.Jalz.2016.06.2381  0.01
2012 Henstridge C. Generating content for social media In Practice. 34: 362-365. DOI: 10.1136/inp.e3323  0.01
2003 Leeb C, Henstridge C, Dewhurst K, Bazeley K. Welfare assessment of working donkeys: Assessment of the impact of an animal healthcare project in West Kenya Animal Welfare. 12: 689-694.  0.01
Hide low-probability matches.